As per the National Survey on Drug Use and Health or NSDUH, 38% of adults in the U.S. were illicit drug users in 2017. This has increased the demand for the drug screening process, driving the global drug screening market. Among regions, North America exhibits the highest demand for drug screening owing to the increasing cases of alcohol and drug abuse. Moreover, North America is anticipated to dominate the global drug screening market owing to the implementation of strict government laws.
This will help mandate the drug screening process across the countries in North America, favouring expansion of the drug screening market size. According to the National Center for Advancing Translational Sciences, around 30% of medications have failed in human trials as they are toxic. This gives rise to a 3D platform, engineered to offer support to living cells and human tissues. The implementation of organs-on-a-chip is likely to be the future of drug testing.
These chips are microfluidic in nature and can help to predict if a drug or a vaccine is safe to humans. It allows an accurate and precise perception regarding the effects of drugs on a human body. Such innovations are expected to further add up to the growth of the market in North America.
Get Sample PDF Brochure @ https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/drug-screening-market-101157
“Poor Infrastructure Facilities May Hamper the Market Growth”
The rising consumption of illicit drugs is projected to boost the drug screening market. In addition to this, the rising prevalence of drug addiction will give significant impetus to growth. As per a survey conducted by the National Survey on Drug Use and Health (NSDUH), approximately 19.7 million adults in the US suffered from mental disorders owing to substance use. Another factor responsible for positively impacting the market is the increasing number of crime rates due to drug abuse. This, as a result, is likely to drive the adoption of drug screening, augmenting the drug screening market growth.
However, strict government laws and regulation are likely to inhibit the growth of the market. Companies find it difficult to introduce any drug in the market owing to such stringent laws. Furthermore, lack of infrastructure facilities especially in developing nations may impede the growth to an extent. Organizations to Re-evaluate their Drug Screening Policies with the Increasing Acceptance of Cannabis
The report profiles some of the leading players operating in the global drug screening market. These include:
• Thermo Fisher Scientific
• Quest Diagnostics
• Laboratory Corporation of America Holdings
• Alfa Scientific Designs
• MPD Inc.
Organizations are going to review their existing drug screening policies owing to the positive wave of cannabis law enforcement. For instance, Quest Diagnostics developed a platform called Drug Testing Index. This platform helps in the detection of drug use by a drug screening process at workplace. Several companies are planning to adopt strategies in order to strengthen their market position. This, as a result, is expected to surge the drug screening market revenue in the forthcoming years.
Some of the recent developments are mentioned below:
August 2017: A UK-based company called Intelligent Fingerprinting Limited announced the launch of a portable fingerprint drug test for the detection of cocaine, cannabis, amphetamines, and opiates. The device has the ability to collect and analyze sample in just 10 minutes.
August 2018: A Canadian-based company called Drager Safety received approval for a new drug-testing device. The device called Dräger DrugTest 5000 is an oral fluid drug used for drug screening.
Inquire Before Buying @ https://www.fortunebusinessinsights.com/enquiry/queries/drug-screening-market-101157
Drug Screening Market Segmentation:
• Analytical Instruments
• Rapid Testing Devices
By Sample Type
• Oral Fluids
By End User
• Criminal Justice
• North America (USA and Canada)
• Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
• Latin America (Brazil, Mexico and Rest of Latin America)
• Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)